P-268 Impact of optimal morphologic response on survival in patients with KRAS wild-type unresectable colorectal liver metastases receiving an anti-EGFR or anti-VEGF agent
2007 ◽
Vol 33
(9)
◽
pp. 1099-1099
2015 ◽
Vol 11
(4)
◽
pp. 160-167
◽